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2Department of Pathology, Hospital Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
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Introduction Bladder reconstruction without using the intestine remains a challenge to this day despite 
the development of new biomaterials and cell cultures. Human bladder engineering is merely anecdotic, 
and mostly in vitro and animal studies have been conducted.
Material and methods In our study using a porcine model, we performed a bladder augmentation using 
an autologous parietal peritoneum graft (peritoneocystoplasty) and determined whether the attachment 
of an acellular collagen-elastin matrix (Group 1) or lack of (Group 2) had better histologic and functional 
results. Thus far, peritoneocystoplasty has rarely been performed or combined with a biomaterial.
Results After 6 weeks, we observed different degrees of retraction of the new bladder wall in both groups, 
although the retraction was lower and the histological analysis showed more signs of regeneration (neo-
angiogenesis and less fibrosis) in Group 1 than when compared with Group 2. No transitional cells were 
found in the new bladder wall in any of the groups, and no differences were observed in the functional 
test results.
Conclusions Performing a peritoneocystoplasty is an easy and safe procedure. The data supports the 
benefit of an acellular collagen–elastin matrix to reinforce bladder regeneration. However, in our study 
we observed too much retraction of the new wall and the histologic results were not acceptable  to con-
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INTRODUCTION
Bladder reconstructive surgery encompasses surgi-
cal procedures involving the substitution or enlarg-
ing of the bladder. Radical cystoprostatectomy due 
to muscle-invasive bladder cancer is the most preva-
lent condition warranting the removal and substitu-
tion of the urinary bladder [1]. Augmentation cys-
toplasty is required in certain types of neurogenic 
bladder dysfunction, interstitial cystitis (painful 
bladder syndrome), and severe radiation- induced 
Citation: Gasanz C, Raventós C, Temprana-Salvador J, et al. Use of an acellular collagen-elastin matrix to support bladder regeneration in a porcine model  
of peritoneocystoplasty. Cent European J Urol. 2018; 71: 353-359.
or urogenital tuberculosis contracted bladder. Cur-
rently, the human intestine is used in daily clinical 
practice to substitute or enlarge the bladder. It has 
many drawbacks, not only due to bowel resection, 
but also to relevant complications related to the con-
tact of the urine with a tissue not biologically pre-
pared for this purpose, which involves an increase 
in morbidity rates [2, 3]. Bladder tissue engineering 
is dedicated to design and produce a material that can 
replace the bladder tissue instead of using the intes-
tine. Mostly in vitro and animal studies have been 
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conducted with different types of biomaterials, cell 
cultures and growth factors [4]. However, the human 
bladder engineering is merely anecdotic and remains 
an enormous challenge to this day [5, 6, 7]. The ideal 
material should be readily biodegradable, biocompat-
ible and useful as a scaffold, so that it could host tis-
sue development [8, 9].
In our study using a porcine model, we made blad-
der augmentations using an autologous parietal 
peritoneum graft (peritoneocystoplasty) and deter-
mined whether the attachment or not of an acellu-
lar collagen–elastin matrix to this peritoneum graft 
had better histologic and functional results. Thus 
far, peritoneocystoplasty has rarely been performed 
or combined with a biomaterial.
MATERIAL AND METHODS
The animals were divided in two groups: Group 1 
was peritoneocystoplasty plus biomaterial and Group 
2 was peritoneocystoplasty without the biomaterial. 
The total survival time of the animals was six weeks.
Animals and ethics statement
Experiments were performed on 16 female hybrid 
pigs (Large White x Landrace) weighing 27–40 kg. 
All procedures were approved by the Animal Experi-
mentation Ethics Committee (registration number: 
20/13) of the Vall d'Hebron Research Institute and 
conducted in compliance with the Spanish legisla-
tion in accordance with the European Union direc-
tives (2010/63/EU). The experiment was categorized 
as a stage 0 (preclinical study) for the evaluation 
of a new medical product according to IDEAL-Device 
(Idea, Development, Evaluation, Assessment and 
Long-term) [10].
Graft preparation
The biomaterial consists of a 1 mm-thick structurally 
intact native collagen matrix coated with α-elastin hy-
drolysate of bovine origin (Matriderm®, MedSkin So-
lution Dr. Suwelack AG, Germany). It is sterilized by 
gamma irradiation after freeze-drying and is stored 
at room temperature. It has been tested in clinical 
trials to treat full-thickness burns, trauma and re-
constructive wounds. It has shown good results when 
applied simultaneously with split-thickness skin 
grafts in  single-stage operative procedures. The ma-
terial promotes cell migration and proliferation and 
encourages early neoangiogenesis [11, 12]. We also 
used a parietal peritoneum graft obtained through 
a midline down laparotomy. A 10×10 cm graft was 
completely dissected from the anterior abdominal 
wall musculature. The graft was later taken folded 
in half, and then folded in half again. It was stored 
in a covered container with a 0.9% sterile saline solu-
tion at room temperature.
Anesthesia and surgical procedure
A urinary catheter was inserted before initiating the 
surgical procedure to perform the first functional test 
(as explained in the functional test section). A lower 
midline laparotomy incision was performed to ac-
cess the peritoneal cavity. After a general inspection, 
we completely dissected the peritoneum graft from 
the anterior abdominal wall musculature and stored 
it. Afterwards, we located the bladder and performed 
a 5×5 cm exeresis of the anterior wall. Afterwards, 
we made simple interrupted stitches of polypropylene 
(Prolene®, Ethicon) around the edges of the exeresis 
(in the serous membrane) as reference points. Six 
weeks later, these marks helped us to identify the sur-
gical borders and measure macroscopically the even-
tual graft shrinkage. After performing these referral 
stitches, we randomly divided the pigs in two groups. 
In Group 1, we substituted the resected bladder wall 
with a 5×5 cm compound graft of peritoneum plus 
the biomaterial. Both were attached easily by con-
tact in the operating theater without glue or stitches. 
The biomaterial was in the inner part of the bladder 
and the peritoneum was in the outer part. The graft 
was sutured to the bladder wall (all layers) with two 
running stitches of poliglecaprone 4-0 (Monocryl®, 
Ethicon). In Group 2, we performed the same pro-
cedure, but only with the peritoneum graft without 
attaching the biomaterial. The final macroscopic re-
sults are shown in Figure 1. The animals kept the 
urinary catheter for 10 days. After six weeks, we re-
peated the functional test and performed the cystec-
tomy and euthanasia. The animals were euthanized 
by receiving an anesthetic IV overdose of 2 g of tio-
barbital (Tiopental®, B. Braun Melsungen AG).
Specimen harvest and histological procedures
The gross examination analysis of the bladder, sub-
sequent to euthanasia, involved four steps: identify 
the new bladder wall formed from the graft, study 
the seroma formation, local infection, and tissue in-
tegrity. In measuring the new bladder wall, the poly-
propylene stitches previously placed along the edges 
of the resected area were very useful. We obtained 
this measure in centimeters and calculated the even-
tual shrinkage rate of the new wall. We used quali-
tative scales to evaluate the rest of the parameters. 
First, the seroma in the new wall was classified into 
A (no alteration) or B (mild or massive seroma). 
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H-score and number of vessels. In order to describe 
the variables we calculated the mean, median, vari-
ance and standard deviation. Comparisons between 
Group 1 and Group 2 were analyzed with the Mann-
Whitney U test using SPSS® (V24.0). Statistically sig-
nificant values were defined as p <0.05.
RESULTS
General considerations and complications  
of the surgical procedure
The original idea of dividing the animals into two 
exact groups was not possible in three cases because 
of the fragility of the peritoneum graft. We could not 
perform adequate stitches because they provoked 
ruptures at the graft edges. In these three cases, we 
added the biomaterial to strengthen the peritoneum 
graft. Thus, we used 11 peritoneum plus biomaterial 
grafts (Group 1) and 5 peritoneum grafts (Group 2) in 
total. As a serious complication, one animal (Group 1) 
required further surgery because of an intraperito-
neal urinary leakage caused by the partial rupture 
of the graft suture line, which was successfully re-
paired. We noticed the importance of cutting the 
tip of the urinary catheter (respecting the balloon) 
to prevent graft damage. All the animals were 
weighed twice: at the beginning and after six weeks. 
Results are shown in Table 1.
Second, we evaluated whether signs of infection 
were present and categorized the signs as either A 
(no alteration) or B (purulent exudate). Lastly, 
we carefully examined the perimeter of the graft 
to study the tissue integration with the normal 
bladder wall and classified it as either A (complete 
integration) or B (narrow areas at the edges or lack 
of integration). The histological analysis was per-
formed by selecting six representative sections of the 
bladder (new wall, transition zones and normal wall). 
These tissue sections were fixed in 4% paraformalde-
hyde, embedded in paraffin, and sectioned at 4 µm. 
These sections were stained using the hematoxylin 
and eosin (H&E), Gömöri trichrome and Elastica 
van Gieson. The slides were qualitatively assessed 
for cellular organization with regard to the vessel 
density, cellular infiltration, fibrosis, presence of uro-
thelial cells and traces of the biomaterial. The quan-
tification of fibrosis and vascular rate was counted 
on a light microscope at 40x magnification field 
(4x objective and 10x ocular). To quantify the fibro-
sis, we used an histoscore (H-score) that was calcu-
lated by assessing the percentage of fibrosis cells and 
the intensity of the Gömöri staining (graded as 0: 
non-staining; 1+: week; 2+: moderate; 3+: strong). 
The final score was calculated [1x(% cells 1+) + 2x 
(% cells 2+) + 3x(% cells 3+)], and it ranged from 
0 to 300. The blood vessels were quantified by aver-
aging the total number in 10 different microscopic 
fields of the new bladder wall per animal.
Functional test
A volume/pressure test by filling the bladder to the 
leak point was performed just before the first surgery 
and before euthanasia. We used an 18 Ch double-lu-
men urinary catheter connected to a custom-designed 
software, and we filled the bladder with normal sa-
line at 25 ml/min. We set the maximum bladder ca-
pacity when the pericatheter leak was detected. 
Note that the functional test before euthanasia was 
made after the laparotomy, so that we could observe 
how the bladder was expanding throughout the fill-
ing process, especially in the graft area.
Statistical analysis
Total number of animals was calculated after the 
preliminary results in relation to the retraction rate 
(we presumed a difference of 60% between Group 
1 and 2). With a power (1- β-risk) of 0.8 and α-risk 
of 0.05, we needed 7 animals per group to find sig-
nificant statistical differences. Univariate analy-
sis was used to describe the animal weight, retrac-
tion, differences in maximum volume and pressure, 
Figure 1. Representative macroscopic steps of the implanta-
tion procedure. A. Peritoneum + biomaterial cystoplasty.  
B. Peritoneum cystoplasty. C. Anterior abdominal wall after 
removing the peritoneum graft. D. Peritoneum graft.
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Macroscopic examination
We did not observe seroma, local infection, or lack 
of integration in any of the groups after six weeks. 
In two cases belonging to Group 1, a 1×1 cm stone 
attached to the new bladder wall was observed (Fig-
ure 2D). The mean retraction in Group 1 was 28.6% 
(10–80%) and that in Group 2 was 72% (60–80%), 
which was statistically significant (p = 0.007). Macro-
scopically, that difference was self-evident, as shown 
in Figure 2. In all cases we observed a correct wall 
thickness without narrow areas (Figure 3).
Histological analysis
In Group 1, the H&E stain examination (Figure 4) of 
the new-born bladder wall tissue at six weeks showed 
mucous ulceration, moderate fibrosis tissue, glandu-
lar cystic cystitis, poor neovascularization and hardly 
any bundle of disorganized smooth muscle tissue. No 
urothelial cells were observed in the new bladder wall, 
although we observed emerging signs of urothelial 
epithelization and chronic inflammatory eosinophilic 
response at the edges. Most of the new vessels were 
found to be subepithelial, and fibrosis was predomi-
nantly found in the deepest part of the tissue (Figu- 
re 5). In addition, traces of the monocryl stitches were 
found, but there were hardly any traces of the bio-
material. In Group 2, the H&E stain showed mucous 
ulceration, massive fibrosis tissue and lack of urothe-
lium and muscle tissue. Using the Gömöri trichrome 
stain, the mean H-score assessment of fibrosis was 40.9 
(10–65) for Group 1 and 129 (50–220) for Group 2, and 
the difference was statistically significant (p = 0.007). 
To quantify the vessels of the new wall, we used the 
H&E and the Elastica van Gieson stain. The average 
number of blood vessels per field in Group 1 was 61.3 
(12–103) and 33.8 (17–52) in Group 2, and the differ-
ence was also statistically significant (p = 0.03).
Functional results
The test was finally conducted on 9 animals (Group 1: 
6, Group 2: 3) because placing the urinary catheter in 
the the remaining animals was not possible because 
of urethral anatomical limitations. The mean pressure 
variation in Group 1 was 3.5 mmHg and that in Group 
2 was −0.3 mmHg, which was not statistically signifi-
cant (p = 0.051). Results are shown in Table 1.
DISCUSSION
Obtaining the best technique and material to per-
form an augmentation cystoplasty or a bladder sub-
stitution without using the intestine remains a chal-
lenge [13, 14]. Nowadays, they can only be offered 
within a clinical trial setting. Since the announce-
ment of the in vitro urinary bladder reconstruction 
by Atala et al., interest in bladder tissue engineering 
has increased [15]. To date, only 18 studies have been 
conducted on humans (approximately 169 patients) 
using biomaterials and all the other studies have 
been performed using animal models or based on in 
vitro tests [6, 16]. The different biomaterials can be 
classified into naturally derived scaffolds (collagen, 
alginate, elastin, fibronectin, and hyaluronic acid), 
acellular tissue matrices (bladder acellular matrix, 
small intestinal submucosa, dermis, gallbladder, and 
amniotic membrane), and synthetic scaffolds (silk-
Table 1. Results of the variables investigated and comparison 
between groups
Variable* Group 1 Group 2 p-value
Weight increase, kg 5.9 ±2.9 8.2 ±3 0.18
Retraction rate, % 28.6 ±19.5 72 ±8.3 <0.05
Fibrosis H-score 40.9 ±18.2 129 ±64 <0.05
Vessels, ** 61.3 ±24.8 33.8 ±13.6 <0.05
Volume variation, mL 30 ±103.7 -46.6 ±61.1 0.16
Pressure variation, mmHg 3.5 ±2.3 -0.3 ±2 0.051
* Values are reported as mean ± standard deviation
** Average number of blood vessels per field (40x magnification)
Figure 2. Macroscopic overview 6 weeks post-surgery.
A, B. Mild retraction in Group 1. See the polypropylene marks 
in Figure 2B. C. Major retraction in Group 2. D. Stone attached 
to the new bladder wall in Group 1.
based materials and different types of poly-α-esters 
as polyglycolic acid) [17]. There are studies that have 
incorporated exogenous growth factors to the bio-
material in order to promote better results in terms 
of cellular repopulation and neovascularization.
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Incorporating these factors could be debatable, since 
sometimes their uniform distribution cannot be as-
sured and high doses could affect the healing process 
[8, 18]. In general, experimental models conducted 
are complex and they usually require autologous 
or stem cell cultures and laboratory procedures that 
are difficult to perform in daily clinical practice. Fur-
thermore, a well-stablished previous plan is always 
needed, and thus the use of biomaterials, cell cultures 
and exogenous growth factors cannot be decided upon 
the perioperative period (e.g., if the surgeon consid-
ers that the intestine cannot be used). Our main rea-
son to perform peritoneocystoplasty with a parietal 
peritoneum graft was due to the relative ease of the 
technique and its reproducibility, the capability to do 
it without cell cultures and other in vitro procedures, 
and its limited experience as a bladder substitute tis-
sue and in combination with a biomaterial. In 1988, 
Youssef et al. performed bladder augmentations in 
rats using a peritoneal graft with a polyglycolic acid 
mesh [19]. After the first month, the histological 
analysis showed a transitional epithelium and mus-
cle fibers on the new wall. In 1990, Weingarten et al. 
performed myoperitoneocystoplasties in six ferrets 
reporting a median increase of 67% of the bladder ca-
pacity, transitional epithelium on the new wall, and 
no complications [20]. Close et al. published a group 
of 10 peritoneocystoplasty procedures in a sheep 
model with poor results. The bladder capacity did not 
increase, and the histological analysis showed an ex-
tensive fibrosis of the new wall [21]. In humans, two 
Figure 3. Representative samples of the bladder wall thickness 
in Group 1. A. Transition area between normal bladder and 
new wall, with the polypropylene marks. B. Mid-sagittal plane 
of the new wall.
Figure 5. Representative histological overview (Gömöri  
trichrome) after 6 weeks. A. Transition area in Group 1.  
See muscle fibers on the righthand side trying to emerge to  
the new wall (left part). B. Fibrosis (H-score 3+) in Group 2.  
C. Predominantly the newly born tissue was in the inner  
part and the fibrosis was in the outer part, in Group 1.
Figure 4. Representative histological overview (hematoxylin 
and eosin) after 6 weeks in Group 1. A. Transition area. Uro-
thelial cells are only present in the normal bladder (right part). 
B. Inflammatory response (left), matrix traces (right). C. Ves-
sels in the new wall.
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of the biomaterial degradation after six weeks, we ob-
tained the same results according to previous experi-
ments on bladder and other organs [29]. The func-
tional results did not significantly change between 
both groups. We believe that the bladder possibly 
balanced the structural changes and maintained the 
same maximum volume and pressure. However, our 
study has its limitations. First, we point out the com-
plex handling of the peritoneum graft that forced us 
to add the biomaterial in some of the animals. This 
issue was the reason why both groups were not equal.
Perhaps we should have increased the number of 
animals to strengthen the statistical results. Second, 
we believe that the survival time of the animals 
should have been longer in order to promote a bet-
ter regeneration of the new wall. Third, in order 
to support the final histological results, we should 
have added an immunohistochemical staining to 
study inflammatory response markers or structural 
proteins (e.g. antibodies against smoothelin, α-actin, 
desmin, pancytokeratin, uroplakin III, etc.) [8, 28, 
30, 31]. Finally, in some cases we faced urethral ana-
tomical limitations, so the functional test could not 
be properly performed in all animals.
CONCLUSIONS
Currently, the clinical application of biomaterials for 
performing a regular bladder reconstruction is not 
immediately forthcoming and experimental methods 
are usually difficult to apply in daily clinical practice. 
Performing a peritoneocystoplasty is an easy and 
safe procedure, uses an autologous graft and does 
not require any preparation. However, at 6 weeks 
we observed too much retraction of the new wall. 
We consider that the histologic results were not good 
enough although the group with the biomaterial had 
better outcomes. In the future, further experiments 
using peritoneum grafts could possibly be conduct-
ed but using different biomaterials, growth factors 
and/or cell cultures. However, replacing the intestine 
as the gold standard tissue for bladder reconstruction 
remains a great challenge.
CONfLICTS Of INTEREST
The authors declare no conflicts of interest.
similar studies (21 patients in total) used a peritoneal 
flap to cover a bladder auto-augmentation [22, 23]. 
After detrusorrhaphy, a segment of the peritoneum 
was harvested by making an inverted U incision and 
tacking it to the bladder to promote the expansion 
of the exposed urothelium. The results were not sat-
isfactory in functional terms. Our reasons for using 
an acellular collagen–elastin matrix were its avail-
ability in the burn unit of our hospital and the lack 
of experience in experimental bladder surgery with 
this type of biomaterial and peritoneum. This matrix 
acts as a scaffold to promote bladder regeneration, 
it is biodegradable and easy to handle, and does not 
induce an immune response. In general, it has bet-
ter results in urothelial epithelialization rather than 
in muscle fiber regeneration, therefore it can finally 
affect the functional outcomes [24].
Our results in a pig model showed that performing 
a peritoneocystoplasty using the parietal peritoneum 
graft was not a good choice because the new wall was 
contracted and was mainly composed of fibrotic tis-
sue. However, when we added an acellular collagen–
elastin matrix to the peritoneum graft, the results 
were better because the retraction rate was lower 
and the histological analysis showed more signs of re-
generation (greater number of vessels and less fibro-
sis). Nevertheless, in that last group the retraction 
was also high, and we found a urinary stone attached 
to the new bladder wall (inner part) in two animals. 
We did not observe transitional cells on the new wall 
in any of the groups. We believe that this outcome 
was probably due to the limited survival time accord-
ing to other studies [8, 24, 25]. We want to emphasize 
that in bladder regeneration, not only is the presence 
of urothelial cells important, but also the muscle fi-
ber regeneration, which we did not properly observe 
in any of the groups. Previous studies on animals 
and humans showed good results in terms of uro-
thelial re-epithelialization, but with an inadequate 
muscle regeneration because it was incomplete, dis-
organized, not well integrated into the new wall, and 
without adequate vascularization or innervation [7]. 
This fact determines the final bladder functionality 
[24, 26]. Some studies have even performed a specif-
ic mechanical analysis to study the tensile strength 
of the new wall [27, 28]. In terms of the high rate 
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